1. Home
  2. WEAV vs PRTC Comparison

WEAV vs PRTC Comparison

Compare WEAV & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weave Communications Inc.

WEAV

Weave Communications Inc.

HOLD

Current Price

$5.41

Market Cap

487.7M

Sector

Technology

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

N/A

Current Price

$17.85

Market Cap

400.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WEAV
PRTC
Founded
2011
2015
Country
United States
United States
Employees
N/A
90
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
487.7M
400.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
WEAV
PRTC
Price
$5.41
$17.85
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
1.2M
3.5K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
7.50
N/A
EPS
N/A
N/A
Revenue
$239,024,000.00
N/A
Revenue This Year
$17.20
N/A
Revenue Next Year
$13.74
N/A
P/E Ratio
N/A
$8.09
Revenue Growth
16.99
N/A
52 Week Low
$4.24
$14.50
52 Week High
$11.32
$19.92

Technical Indicators

Market Signals
Indicator
WEAV
PRTC
Relative Strength Index (RSI) 59.77 61.15
Support Level $5.37 $16.60
Resistance Level $5.70 $18.12
Average True Range (ATR) 0.25 0.49
MACD 0.10 0.25
Stochastic Oscillator 76.68 82.30

Price Performance

Historical Comparison
WEAV
PRTC

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: